Atención médica de calidadDescubra por qué Mayo Clinic es el mejor lugar para atenderse. Pide una cita.
Research conducted by Samuel O. Antwi, Ph.D., focuses on the molecular epidemiology of cancers of the pancreas and liver. He investigates the genetic, epigenetic and nongenetic origins of liver and pancreatic cancers. Dr. Antwi seeks to understand how individual biological differences act independently or in concert with lifestyle factors to influence the risk for these cancers.
Dr. Antwi and his team use biospecimens obtained from individuals with cancer and individuals without cancer to perform genetic sequencing studies and mass spectrometry-based epigenetic analyses. The team creates molecular assays to identify novel factors associated with the development of pancreatic and liver cancers.
Dr. Antwi's laboratory also analyzes data from structured research questionnaires to identify nongenetic risk factors of liver and pancreatic cancers. His team examines the combined effects of the nongenetic factors and host biological differences on the risk of cancer development. A keen focus of Dr. Antwi 's research is biologically meaningful data analysis contributing to practical actions that benefit patients and populations.
The goal of Dr. Antwi's research is to provide sound molecular epidemiologic evidence to support the translation of findings from his research to cancer prevention, quantitative risk assessment and early detection of cancer before it progresses to incurable disease.
Infórmate sobre los ensayos clínicos que abordan preguntas científicas específicas sobre la salud humana y las enfermedades.
Ver mis estudios.
Explora todos los estudios de investigación en Mayo Clinic.
Ver las conclusiones revisadas por colegas que publiqué como resultado de mi investigación.